NCT05990881View on ClinicalTrials.gov

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 27, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Carpometacarpal SprainThumb SprainClostridium; Botulinum
Interventions
DRUG

Botulinum toxin

Patients in this group will receive an injection of Botulinum toxin.

DRUG

Standard-of-care corticosteroid injections

Patients in this group will receive an injection of corticosteroid injections, which are considered standard of care.

Trial Locations (1)

02905

RECRUITING

235 Plain Street, Providence

All Listed Sponsors
lead

Rhode Island Hospital

OTHER